|
⚲
|
| Keyboard |
| Drapkin Kimberlee C
✚
|
|
|---|---|
| CIK # | 0001340881 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001340881] | |
| 4 | [0001340881] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| LENZ Therapeutics Inc | |
| Drapkin Kimberlee C | |
| Climb Bio Inc | |
| Acumen Pharmaceuticals Inc | |
| Kineta Inc/DE | |
| Jounce Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kineta Inc/DE KANT
Common Stock
|
2025-06-30 | Disposed to issuer | 13,794 | ||
|
Kineta Inc/DE KANT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Disposed to issuer | 20,000 | $0.00 | |
|
Kineta Inc/DE KANT
Common Stock
|
2025-06-25 | Grant | 6,000 | $0.00 | |
|
Kineta Inc/DE KANT
Common Stock
|
2025-06-23 | Tax withheld | 4,706 | $0.26 | 1,224 |
|
Kineta Inc/DE KANT
Common Stock
|
2025-06-23 | Option exercise | 12,500 | $0.61 | 7,625 |
|
Kineta Inc/DE KANT
Stock Option (Right to Buy) · derivative
|
2025-06-23 | Option exercise | 12,500 | $0.00 | |
|
LENZ Therapeutics Inc LENZ
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 13,500 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Stock Option (right to buy) · derivative
|
2025-06-04 | Grant | 19,500 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2025-06-04 | Grant | 12,800 | $0.00 | |
|
Climb Bio Inc CLYM
Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 40,000 | $0.00 | |
|
Climb Bio Inc CLYM
Stock Option (Right to Buy) · derivative
|
2025-03-28 | Grant | 80,000 | $0.00 | |
|
Kineta Inc/DE KA
Stock Option (Right to Buy) · derivative
|
2024-09-04 | Grant | 12,500 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Stock Option (right to buy) · derivative
|
2024-06-10 | Grant | 25,000 | $0.00 | |
|
LENZ Therapeutics Inc LENZ
Stock Option (right to buy) · derivative
|
2024-03-21 | Grant | 27,000 | $0.00 | |
|
LENZ Therapeutics Inc GRPH
Stock Option (right to buy) · derivative
|
2023-07-28 | Grant | 40,000 | $0.00 | |
|
Kineta Inc/DE KA
Stock Option (Right to Buy) · derivative
|
2023-07-01 | Grant | 20,000 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Stock Option (right to buy) · derivative
|
2023-06-06 | Grant | 25,000 | $0.00 | |
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2023-05-03 | Tender | 25,751 | ||
|
Jounce Therapeutics Inc JNCE
Common Stock
|
2023-05-03 | Tender | 40,267 | ||
|
Jounce Therapeutics Inc JNCE
Stock Option (Right to Buy) · derivative
|
2023-05-03 | Disposed to issuer | 8,130 | ||
| showing 20 of 74 most recent transactions | |||||